SYNTHESIS AND PLATELET-ACTIVATING-FACTOR (PAF)-ANTAGONISTIC ACTIVITIES OF 1,4-DISUBSTITUTED PIPERAZINE DERIVATIVES

被引：0
|
作者：
FUKUSHI, H
MABUCHI, H
ITOH, K
TERASHITA, Z
NISHIKAWA, K
SUGIHARA, H
机构：
[1] TAKEDA CHEM IND LTD, PHARMACEUT RES LABS 2, YODOGAWA KU, OSAKA 532, JAPAN
[2] TAKEDA CHEM IND LTD, PHARMACEUT RES LABS 3, YODOGAWA KU, OSAKA 532, JAPAN
[3] TAKEDA CHEM IND LTD, DIV PHARMACEUT RES, OSAKA 532, JAPAN
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 1994年 / 42卷 / 03期
关键词：
PAF ANTAGONIST; STRUCTURE ACTIVITY RELATIONSHIP; 1,4-DISUBSTITUTED PIPERAZINE; 1-(6-METHOXY-3,4-DIHYDRO-2-NAPHTHOYL)-4-(3,4,5-TRIMETHOXYBENZYL)PIPERAZINE; 1-(2,3-DIMETHOXY-6,7-DIHYDRO-5H-BENZOCYCLOHEPTEN-8-YLCARBONYL)-4-(3,4,5-TRIMETHOXYBENZOYL)PIPERAZINE;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
During the screening of novel platelet-activating factor (PAF) antagonists, we found that 1-(6-methoxy-3,4-dihydro-2-naphthoyl)-4-(3,4,5-trimethoxybenzyl)piperazine and its 4-(3,4,5-trimethoxybenzoyl)piperazine derivatives (1b, 2b) exerted in vitro and in vivo PAF-antagonistic activities. Modifications of the 1-acyl group, the substituent at the 4-position and the piperazine ring of 1a and 2b were examined and from this series 1-(2,3-dimethoxy-6,7-dihydro-5H-benzocyclohepten-8-ylcarbonyl)-4-(3,4,5-trimethoxybenzoyl)piperazine (2g) was found to be one of the most potent PAF antagonists.
引用
收藏
页码：541 / 550
页数：10
相关论文
共 50 条
  • [21] SYNTHESIS AND PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR ANTAGONIST ACTIVITY OF 2,5-DIARYLCYCLOPENTANOL DERIVATIVES
    PRASHAD, M
    TOMESCH, JC
    WAREING, JR
    LARSEN, D
    DEFEX, H
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1992, 27 (04) : 413 - 418
  • [22] PLATELET-ACTIVATING-FACTOR (PAF) AND NONSPECIFIC BRONCHIAL HYPERRESPONSIVENESS
    ILYAS, M
    MCSHARRY, C
    PATEL, KR
    THORAX, 1992, 47 (03) : P255 - P255
  • [23] RELEASE OF PLATELET-ACTIVATING-FACTOR (PAF) AFTER IRRADIATION
    HUANG, L
    MOLTENI, A
    WARD, WF
    TAYLOR, JM
    CRAWFORD, SE
    HSUEH, W
    FASEB JOURNAL, 1993, 7 (04): : A641 - A641
  • [24] A PARTIAL PHARMACOPHORE FOR THE PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR
    HODGKIN, EE
    MILLER, A
    WHITTAKER, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (06) : 597 - 602
  • [25] EXPRESSION OF PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR IN LYMPHOCYTES
    SIMON, HU
    SIMINOVITCH, KA
    MILLS, GB
    BLASER, K
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A313 - A313
  • [26] IMMUNOFLUORESCENT LOCALIZATION OF PLATELET-ACTIVATING-FACTOR (PAF) IN THE RAT
    HIRASHIMA, Y
    KATO, R
    ENDO, S
    TAKAKU, A
    KARASAWA, K
    NOJIMA, S
    HISTOCHEMICAL JOURNAL, 1993, 25 (11): : 830 - 833
  • [27] CONFORMATIONALLY RESTRICTED ANALOGS OF PLATELET-ACTIVATING-FACTOR (PAF)
    HADVARY, P
    WELLER, T
    HELVETICA CHIMICA ACTA, 1986, 69 (08) : 1862 - 1871
  • [28] SYNTHESIS OF PLATELET-ACTIVATING-FACTOR BY HUMAN MONOCYTES STIMULATED BY PLATELET-ACTIVATING-FACTOR
    VALONE, FH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 87 (03) : 715 - 720
  • [29] Platelet activating factor (PAF) antagonistic activities of compounds isolated from Guttiferae species
    bin Jantan, I
    Jalil, J
    Abd Warif, NM
    PHARMACEUTICAL BIOLOGY, 2001, 39 (04) : 243 - 246
  • [30] Synthesis and anticancer activities of novel 1,4-disubstituted phthalazines
    Li, Juan
    Zhao, Yan-Fang
    Yuan, Xiao-Ye
    Xu, Jing-Xiong
    Gong, Ping
    MOLECULES, 2006, 11 (07) : 574 - 582
12345